Synthesis of a TiO 2 –CuO@rGO Ternary Nanocomposite for Effective Photocatalytic Treatment of the Methylene Blue Dye
ACS Omega · 17.02.2026 · 11 (6) · 9861-9875
DOI: 10.1021/acsomega.5c10557 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 05.02.2026. Verfasst von Rashid Nawaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Abdul Wali Khan University, Mardan, KP 23200, Pakistan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Prince Sultan University, Abdul Wali Khan University Mardan.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry, Abdul Wali Khan University, Mardan, KP 23200, Pakistan.
- Energy, Water and Environment Lab, College of Sciences and Humanities, Prince Sultan University, Riyadh 11586, Saudi Arabia.
ORCID-Profile: Abbas Khan, Muhammad Humayun
Förderung
- Prince Sultan University
- Abdul Wali Khan University Mardan
Zitieren
APA
Nawaz, R., Khan, A., Rahman, U. U., Ullah, A., Bououdina, M., Humayun, M., & Khan, R. D. (2026). Synthesis of a TiO 2 –CuO@rGO Ternary Nanocomposite for Effective Photocatalytic Treatment of the Methylene Blue Dye. ACS Omega, 11(6), 9861-9875. https://doi.org/10.1021/acsomega.5c10557
Vancouver
Nawaz R, Khan A, Rahman UU, Ullah A, Bououdina M, Humayun M, et al. Synthesis of a TiO 2 –CuO@rGO Ternary Nanocomposite for Effective Photocatalytic Treatment of the Methylene Blue Dye. ACS Omega. 2026;11(6):9861-9875. doi:10.1021/acsomega.5c10557
BibTeX
@article{Nawaz2026,
author = {Nawaz, Rashid and Khan, Abbas and Rahman, Ubaid Ur and Ullah, Asad and Bououdina, Mohamed and Humayun, Muhammad and Khan, Rehanud Din},
title = {Synthesis of a TiO 2 –CuO@rGO Ternary Nanocomposite for Effective Photocatalytic Treatment of the Methylene Blue Dye},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {6},
pages = {9861--9875},
doi = {10.1021/acsomega.5c10557}
}
EUVIMED